Influenza
10 competing products in clinical development for Influenza.
Pipeline by Phase
Phase 12
Phase 23
Phase 35
All Products (10)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| CAIV-T | Pfizer | Phase 3 | Completed | 40 |
| Baloxavir Marboxil + Placebo to Baloxavir Marboxil + Oseltamivir + Placebo to Oseltamivir | Shionogi | Phase 3 | Completed | 40 |
| Baloxavir Marboxil + Placebo to Baloxavir Marboxil + Oseltamivir + Placebo to Oseltamivir | Shionogi | Phase 3 | Completed | 40 |
| Vaccine | Comac Medical | Phase 3 | Completed | 30 |
| mRNA-1010 | Moderna | Phase 2 | Completed | 0 |
| VAL-506440 | Moderna | Phase 1 | Completed | 0 |
| VAL-339851 | Moderna | Phase 1 | Completed | 0 |
| mRNA-1018-H5 | Moderna | Phase 3 | Recruiting | 0 |
| mRNA-1018 for H5N8 | Moderna | Phase 2 | Completed | 0 |
| mRNA-1010 | Moderna | Phase 2 | Completed | 0 |